CN114426511A - Method for preparing chiral spiro [2.4] heptane compounds through palladium-catalyzed asymmetric cycloaddition reaction - Google Patents

Method for preparing chiral spiro [2.4] heptane compounds through palladium-catalyzed asymmetric cycloaddition reaction Download PDF

Info

Publication number
CN114426511A
CN114426511A CN202111668135.1A CN202111668135A CN114426511A CN 114426511 A CN114426511 A CN 114426511A CN 202111668135 A CN202111668135 A CN 202111668135A CN 114426511 A CN114426511 A CN 114426511A
Authority
CN
China
Prior art keywords
compound
palladium
formula
reaction
spiro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202111668135.1A
Other languages
Chinese (zh)
Inventor
刘继田
高灿
张婷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shandong University
Original Assignee
Shandong University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shandong University filed Critical Shandong University
Priority to CN202111668135.1A priority Critical patent/CN114426511A/en
Publication of CN114426511A publication Critical patent/CN114426511A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/18Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
    • B01J31/1845Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms the ligands containing phosphorus
    • B01J31/1885Ligands comprising two different formal oxidation states of phosphorus in one at least bidentate ligand, e.g. phosphite/phosphinite
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80Complexes comprising metals of Group VIII as the central metal
    • B01J2531/82Metals of the platinum group
    • B01J2531/824Palladium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention provides a method for preparing chiral spiro [2.4] by palladium-catalyzed asymmetric cycloaddition reaction]A process for producing heptanes, comprising the steps of: in a solvent, under the concerted catalysis of a palladium catalysis system and an organic urea tertiary amine catalyst, a gamma-methylene-delta-valerolactone compound I and an indole nitroolefin compound II undergo a cycloaddition reaction to obtain chiral spiro [2.4]A heptane compound III; the palladium catalytic system consists of a palladium catalyst and a chiral ligand, and the chiral ligand has a structure shown in a formula IV; the organic urea tertiary amine catalyst has a structure shown in a formula V. The spiro compound is constructed by the palladium-catalyzed asymmetric cycloaddition reaction, and the method has the advantages of low catalyst cost, convenient operation, wide substrate application range, cheap and easily obtained reaction raw materials and the like.

Description

Method for preparing chiral spiro [2.4] heptane compounds through palladium-catalyzed asymmetric cycloaddition reaction
Technical Field
The invention relates to a method for preparing chiral spiro [2.4] heptane compounds by palladium-catalyzed asymmetric cycloaddition reaction, belonging to the technical field of organic synthesis.
Background
Transition metal-catalyzed intermolecular cycloaddition reactions are one of the most effective methods for synthesizing cyclic frameworks. Transition metal-catalyzed dipolar cycloaddition reactions between active zwitterionic intermediates and unsaturated acceptors have been widely used in the construction of multifunctional cyclic compounds since the first report in 1979 by Trost and Chan of the formation of 1, 3-dipolar intermediates from 2-acetoxymethyl-3-allyltrimethylsilane (Trost, B, M.; Chan, D, M, T.J.am.chem.Soc.,1979,101, 6429-. In 2007, Shintani and Hayashi reported for the first time that the reaction precursor gamma-methylene-delta-valerolactone (GMDVs) can be decarboxylated under the action of zero-valent palladium to generate 1, 4-dipoles (Shintani, R.; Murakami, M.; Hayashi, T.J.Am.chem.Soc.,2007,129,12356-12357.), and therefore, GMDVs becomes a reliable and powerful zwitterionic intermediate for constructing various carbocycles and heterocycles. Most of the current research is mainly focused on Tsuji-Trost type intramolecular nucleophilic attack of activated unsaturated olefin on one of the two terminal carbons of the pi-allylpalladium intermediate, resulting in a [4+2] cycloaddition product.
In contrast, asymmetric [3+2] cycloaddition reactions are rarely reported in which the central carbon of a pi-allylpalladium intermediate is attacked by an anion to form a polysubstituted chiral spiro ring. In 2012, Shintani and Hayashi reported that palladium-catalyzed cycloaddition of GMDVs to isocyanates to [3+2]/[4+2] yielded 2-pyrrolidones (Shintani, r.; Ito, T.; Hayashi, T. org. lett.,2012,14, 2410-2413; Shintani, r.; Ito, T.; Nagamoto, m.; Otomo, h.; Hayashi, T. chem. commu., 2012,48,9936-9938.), but the substrates were limited to isocyanate-based compounds and the functional group tolerance range was small. In 2020, the Trost subject group reports two unique asymmetric cycloaddition routes involving 1, 4-dipoles of fat species, and chiral spiro [2.4] heptanes compounds (Trost, B, M.; Jiao, Z.; Liu, Y.; Min C.; Hung, C, -I.J.am.chem.Soc.,2020,142,18628 and 18636) are successfully synthesized, however, only 4 successful synthetic product cases are reported in the article, and the application value is low. In 2021, our group reported the synthesis of tetrahydrobenzo [ b ] mustard derivatives (Gao, C.; Wang, X.; Liu, J.; Li, X.ACS Cat. 2021,11, 2684) -one) by palladium catalyzed asymmetric [4+4] cycloaddition of GMDVs to form 1, 4-dipolar zwitterions with anthracenes.
As is clear from the above, since the application range of the conventional synthesis method is small, it is very necessary to develop an asymmetric cyclopropanation reaction catalyzed by palladium in order to search for a new reaction mode of a 1, 4-dipole to prepare a chiral spiro [2.4] heptane compound.
Disclosure of Invention
Aiming at the defects of the prior art, the invention provides a method for preparing chiral spiro [2.4] heptane compounds by palladium-catalyzed asymmetric cycloaddition reaction. The invention uses the palladium catalyst with simple structure and low price and the chiral ligand which is simple and easy to synthesize to complete the high-efficiency asymmetric synthesis of the chiral spiro [2.4] heptane compounds.
The technical scheme of the invention is as follows:
a process for the preparation of chiral spiro [2.4] heptanes by palladium catalysed asymmetric cycloaddition comprising the steps of:
in a solvent, under the concerted catalysis of a palladium catalysis system and an organic urea tertiary amine catalyst, performing cycloaddition reaction on a gamma-methylene-delta-valerolactone compound I and an indole nitroolefin compound II to obtain a chiral spiro [2.4] heptane compound III; the palladium catalytic system consists of a palladium catalyst and a chiral ligand, and the chiral ligand has a structure shown in a formula IV; the organic urea tertiary amine catalyst has a structure shown in a formula V;
Figure BDA0003448849760000021
wherein in the structural formula of the compound of the formula I, R1Selected from C1-C3 alkyl or benzyl; ar is phenyl or substituted phenyl, and the substituent of the substituted phenyl is trifluoromethyl, halogen or methyl formate;
in the structural formula of the compound of formula II, R2Is hydrogen, cyano, halogen or C1-C3 alkyl;
in the formula of the compound of formula III, the substituent R1Ar is the same as the structural formula of the compound shown in the formula I; substituent R2And the substitution position is the same as that in the structural formula of the compound shown in the formula II.
Preferred according to the invention are compounds of the formula I in which R is1Is methyl, ethyl or benzyl; ar is phenyl, 4-trifluoromethylphenyl and 4-chlorphenyl4-bromophenyl, 4-carbomethoxyphenyl or 3-carbomethoxyphenyl.
Preferably, according to the invention, the solvent is tetrahydrofuran, anisole or N, N-dimethylformamide; the ratio of the volume of the solvent to the mole number of the indole nitroolefin compound II is 1mL: 0.05-0.5 mmol; the solvent is an anhydrous and oxygen-free solvent.
According to a preferred embodiment of the invention, the palladium catalyst is Pd2(dba)3·CHCl3Or Pd (PPh)3)4(ii) a The molar ratio of palladium in the palladium catalyst to the indole nitroolefin compound II is 0.1-0.11: 1; the molar ratio of palladium to the chiral ligand in the palladium catalyst is 1: 2-2.2.
According to the invention, the molar ratio of the organic urea tertiary amine catalyst to the palladium in the palladium catalyst is preferably 1: 1.
According to the invention, the mol ratio of the gamma-methylene-delta-valerolactone compound I to the indole nitroolefin compound II is 1-1.2: 1.
According to the invention, the reaction system is preferably added
Figure BDA0003448849760000022
A molecular sieve; the described
Figure BDA0003448849760000023
The ratio of the mass of the molecular sieve to the mole number of the indole nitroolefin compound II is 2-5 g:1mmol, and the function is to further remove a trace amount of water in the reaction system.
Preferably, according to the invention, the cycloaddition reaction is carried out under a protective gas atmosphere, the protective gas being nitrogen or argon.
According to the invention, the temperature of the cycloaddition reaction is preferably-30-0 ℃, and more preferably-10-0 ℃.
According to the invention, the time of the cycloaddition reaction is preferably 1-14 h, the reaction process is monitored by TLC in the reaction process, and the reaction is completed when the indole nitroolefin compound II disappears.
According to the invention, after the cycloaddition reaction of the gamma-methylene-delta-valerolactone I and the indole nitroolefin compound II, the product can be separated and characterized by a conventional separation and purification method. Preferably, the post-treatment steps of the reaction liquid obtained after the cycloaddition reaction of the gamma-methylene-delta-valerolactone I and the indole nitroolefin compound are as follows: removing the solvent from the reaction liquid, and performing silica gel column chromatography separation on the obtained crude product to obtain a chiral spiro [2.4] heptane compound III, wherein the eluent is a mixed solvent of ethyl acetate and petroleum ether, and the volume ratio of the ethyl acetate to the petroleum ether in the mixed solvent is 0.01-0.5: 1.
According to the invention, the preparation method of the chiral ligand is the prior art and can be prepared by reference (chem.Sci.2018,3, 2628-2632.).
According to the invention, the gamma-methylene-delta-valerolactone compound I is synthesized by a known method from 2-methylene-1, 3-propanediol and corresponding aryl carboxylic ester (see a document: J.Am.chem.Soc.2007,129,12356-12357), and the reaction route is shown as follows:
Figure BDA0003448849760000031
in the above formula, the substituent R1Ar is as described above.
According to the invention, the indole nitroolefin compound II is synthesized by a known method from 3-indole formaldehydes with different substituents (see the literature: RSC adv.,2018,8,5702-5713.), and the reaction route is shown as follows:
Figure BDA0003448849760000032
in the above formula, the substituent R2As described above.
The invention has the following technical characteristics and beneficial effects:
1. the invention takes gamma-methylene-delta-valerolactone compound I and indole nitroolefin compound II substituted by different substituents as raw materials, takes an organic catalyst as a synergistic catalyst, and generates asymmetric [3+2] cycloaddition reaction under the action of a palladium catalyst and a chiral ligand to generate a cycloaddition product chiral spiro [2.4] heptane compound III with high selectivity. The method can generate chiral spiro [2.4] heptane compounds with high stereoselectivity and regioselectivity, and carry out efficient asymmetric synthesis on the chiral spiro [2.4] heptane compounds.
2. According to the invention, a large number of chiral ligands and catalysts with different skeletons are screened, so that the palladium catalyst with a simple structure and low price and the chiral ligand which is simple and easy to synthesize are finally confirmed to be used as a catalytic system, and the catalyst has the advantages of low cost, high efficiency and small using amount of the catalyst; the invention adopts a palladium chiral ligand catalytic system and an organic urea tertiary amine catalyst to carry out concerted catalytic reaction, has the advantage of controlling reaction selectivity, has good diastereoselectivity (dr is more than 12: 1) and high corresponding selectivity (ee can be more than 95%); the method has the advantages of cheap and easily-obtained reaction raw materials, good atom economy, wide substrate application range, mild reaction conditions, convenient and simple operation and high yield.
Detailed Description
The present invention will be described in further detail with reference to specific examples, but the present invention is not limited thereto.
The experimental methods described in the examples are all conventional methods unless otherwise specified; the reagents and starting materials, unless otherwise specified, are commercially available or may be prepared according to known methods.
The solvents used in the examples were treated with anhydrous and oxygen-free treatment, which was carried out according to the prior art.
The organic urea tertiary amine catalyst V used in the examples can be synthesized by known methods.
The chiral ligand IV (11bS) -N- (di (naphthalene-2-yl) methyl) -N-methyldiphthalene [2,1-d:1',2' -f ] [1,3,2] phosphohept-4-amine used in the examples was prepared as follows:
slowly dripping 6.9mL of triethylamine into 50mL of 0.2mol/L phosphorus trichloride dichloromethane solution at the temperature of 0-5 ℃, wherein the dripping time is 20min, heating to room temperature after finishing dripping, then adding 3.0g of a compound shown in the formula VII, continuously stirring for 5h at room temperature, then adding 2.9g of a compound shown in the formula VI, stirring for 12h at room temperature, and finishing the reaction; removing the solvent from the obtained reaction liquid by rotary evaporation, purifying by using a silica gel chromatographic column to obtain a chiral ligand IV with an ee value of 99 percent, wherein an eluent is a mixed solvent of ethyl acetate and petroleum ether, and the volume ratio of the ethyl acetate to the petroleum ether in the mixed solvent is 0.02: 1; the reaction scheme is as follows:
Figure BDA0003448849760000041
example 1
Synthesis of benzyl (5R,6S,7R) -6- (1-methyl-1H-indol-3-yl) -7-nitro-5-phenylspiro [2.4] heptane-5-carboxylate IIIaa
The reaction route is as follows:
Figure BDA0003448849760000051
to a 5mL round bottom flask, under nitrogen, was added 5-methylene-2-oxo-3-phenyltetrahydro-2H-pyran-3-carboxylic acid benzyl ester Ia (39mg), 1-methyl-3- (2-nitrovinyl) -1H-indole IIa (20mg), palladium catalyst Pd2(dba)3·CHCl3(5.2mg), chiral ligand IV (13.4mg), organic urea tertiary amine catalyst V (4.4mg) and
Figure BDA0003448849760000052
300mg of molecular sieve, 1mL of tetrahydrofuran is added, the flask is then brought to-10 ℃ and stirred for 12h, and the completion of IIa reaction is detected by TLC. Removing the solvent from the reaction solution obtained by the reaction, and separating and purifying the obtained crude product by column chromatography (ethyl acetate: petroleum ether ═ 1: 20-1: 5v/v) to obtain a colorless oily substance IIIaa (5R,6S,7R) -6- (1-methyl-1H-indol-3-yl) -7-nitro-5-phenyl spiro [2.4]Benzyl heptane-5-carboxylate 35mg, yield 73%.
The characterization data of the product (IIIaa) obtained are as follows:
colorless oil, 35mg, 73% yield; dr ═ 6:1, 94% ee;
Figure BDA0003448849760000053
(0.1,CH2Cl2);[Daicel
Figure BDA0003448849760000054
IC-U(0.46cm×25cm),n-hexane/2-propanol=90/10,v=1mL·min-1,λ=254nm,t(major)=13.3min,t(minor)=14.2min];
1H NMR(400MHz,CDCl3)δ0.73-0.81(m,1H),0.85-0.93(m,1H),1.07-1.14(m,1H),1.15-1.21(m,1H),2.63(d,J=13.8Hz,1H),2.95(d,J=13.8Hz,1H),3.55(s,3H),5.00-5.04(m,2H),5.18(d,J=12.4Hz,1H),5.36(d,J=10Hz,1H),6.11(s,1H),6.96(ddd,J=8.0,6.7,1.2Hz,1H),7.04(d,J=7.5Hz,2H),7.08–7.19(m,6H),7.20(dt,J=9.3,3.3Hz,2H),7.28(dd,J=5.9,2.6Hz,3H);
13C NMR(100MHz,CDCl3)δ13C NMR(101MHz,CDCl3)δ14.4,17.6,23.2,32.7,44.5,50.2,60.9,67.0,97.5,108.9,109.00,119.2,119.8,121.4,127.0,127.4,127.8,128.1,128.2,128.5,128.6,128.8,135.7,136.5,138.9,174.2;
HRMS(ESI)m/z calcd.for C30H29N2O4[M+H]+:481.2122,found:481.2121。
example 2
Synthesis of (5R,6S,7R) -6- (6-fluoro-1-methyl-1H-indol-3-yl) -7-nitro-5-phenylspiro [2.4] heptane-5-carboxylic acid benzyl ester IIIab
The reaction route is as follows:
Figure BDA0003448849760000061
to a 5mL round bottom flask, under nitrogen, was added 5-methylene-2-oxo-3-phenyltetrahydro-2H-pyran-3-carboxylic acid benzyl ester Ia (39mg), 6-fluoro-1-methyl-3- (2-nitrovinyl) -1H-indole IIb (22mg), palladium catalyst Pd2(dba)3·CHCl3(5.2mg), chiral ligand IV (13.4mg), organic urea tertiary amine V (4.4mg) and
Figure BDA0003448849760000064
molecular sieves 300mg, then tetrahydrofuran 1mL, then the flask was brought to-10 ℃ and stirred for 12h, and IIb reaction was checked by TLC to be complete. Removing the solvent from the reaction solution obtained by the reaction, and separating and purifying the obtained crude product by column chromatography (ethyl acetate: petroleum ether: 1: 20-1: 5v/v) to obtain a colorless oily substance IIIab (5R,6S,7R) -6- (6-fluoro-1-methyl-1H-indol-3-yl) -7-nitro-5-phenyl spiro [ 2.4: (1-methyl-5-phenyl) spiro [2]Benzyl heptane-5-carboxylate 27mg, yield 54%.
The characterization data of the product (IIIab) obtained are as follows:
colorless oil, 27mg, 54% yield; dr 2:1, 88% ee;
Figure BDA0003448849760000062
(0.1,CH2Cl2);[Daicel
Figure BDA0003448849760000063
IA-U(0.46cm×25cm),n-hexane/2-propanol=95/5,v=1mL·min-1,λ=254nm,t(major)=15.2min,t(minor)=18.6min];
1H NMR(400MHz,CDCl3)δ0.72–0.79(m,1H),0.83–0.89(m,1H),1.09-1.13(m,1H),1.16-1.20(m,1H),2.61(d,J=13.8Hz,1H),2.91(d,J=13.8Hz,1H),3.49(s,3H),4.96-5.03(m,2H),5.18(d,J=12.4Hz,1H),5.29(d,J=8.0Hz,1H),6.08(s,1H),6.49–6.59(m,1H),6.70(td,J=9.2,2.4Hz,1H),6.78–6.84(m,1H),7.02(dd,J=7.2,1.8Hz,2H),7.12–7.18(m,5H),7.25–7.30(m,3H);
13C NMR(100MHz,CDCl3)δ14.4,17.6,23.1,32.8,44.5,50.2,60.7,67.0,95.3(d,J=26.0Hz),97.3,108.0(d,J=24.2Hz),109.2,120.7(d,J=10.0Hz),126.9,127.5,127.9,128.2,128.3(d,J=2.3Hz),128.4,128.5,128.6,135.7,136.5(d,J=11.9Hz),138.8,159.7(d,J=236.3Hz),174.1;
HRMS(ESI)m/z calcd.for C30H28FN2O4[M+H]+:499.2028,found:499.2023。
example 3
Synthesis of benzyl (5R,6S,7R) -6- (6-bromo-1-methyl-1H-indol-3-yl) -7-nitro-5-phenylspiro [2.4] heptane-5-carboxylate IIIac
The reaction route is as follows:
Figure BDA0003448849760000071
to a 5mL round bottom flask, under nitrogen, was added 5-methylene-2-oxo-3-phenyltetrahydro-2H-pyran-3-carboxylic acid benzyl ester Ia (39mg), 6-bromo-1-methyl-3- (2-nitrovinyl) -1H-indole IIc (28mg), palladium catalyst Pd2(dba)3·CHCl3(5.2mg), chiral ligand IV (13.4mg), organic urea tertiary amine catalyst V (4.4mg) and
Figure BDA0003448849760000072
molecular sieves 300mg, then tetrahydrofuran 1mL, then the flask was placed at-10 ℃ and stirred for 12h, and IIc reaction was complete by TLC. Removing the solvent from the reaction solution obtained by the reaction, and separating and purifying the obtained crude product by column chromatography (ethyl acetate: petroleum ether: 1: 20-1: 5v/v) to obtain a colorless oily substance IIIac (5R,6S,7R) -6- (6-bromo-1-methyl-1H-indol-3-yl) -7-nitro-5-phenyl spiro [ 2.4%]Benzyl heptane-5-carboxylate 36mg, yield 65%.
The characterization data of the product (IIIac) obtained are as follows:
colorless oil, 36mg, 65% yield; dr ═ 5:1, 94% ee;
Figure BDA0003448849760000073
(0.1,CH2Cl2);[Daicel
Figure BDA0003448849760000074
IA-U(0.46cm×25cm),n-hexane/2-propanol=97/3,v=1mL·min-1,λ=254nm,t(major)=22.0min,t(minor)=25.6min];
1H NMR(400MHz,CDCl3)δ0.74-0.79(m,1H),0.85-0.89(m,1H),1.07-1.14(m,1H),1.17-1.22(m,1H),2.61(d,J=13.8Hz,1H),2.91(d,J=13.8Hz,1H),3.51(s,3H),4.97-5.03(m,2H),5.17(d,J=12.4Hz,1H),5.28(d,J=10.4Hz,1H),6.07(s,1H),7.00-7.04(t,J=8.4Hz,3H),7.07-7.09(d,J=8.6Hz,1H),7.14–7.19(m,4H),7.23(d,J=7.4Hz,1H),7.27-7.28(m,2H),7.33-7.34(m,2H)
13C NMR(100MHz,CDCl3)δ14.5,17.5,23.1,32.8,44.5,50.1,60.6,67.1,97.1,109.3,112.1,115.2,121.1,122.5,126.7,126.9,127.5,127.9,128.2,128.3,128.5,129.5,135.6,137.3,138.8,174.1
HRMS(ESI)m/z calcd.for C30H28BrN2O4[M+H]+:559.1227,found:559.1224。
example 4
Synthesis of benzyl (5R,6S,7R) -6- (5-cyano-1-methyl-1H-indol-3-yl) -5- (4- (methoxycarbonyl) phenyl) -7-nitro-spiro [2.4] heptane-5-carboxylate IIIbd
The reaction route is as follows:
Figure BDA0003448849760000081
to a 5mL round bottom flask, under nitrogen, was added 5-methylene-2-oxo-3- (4- (methoxycarbonyl) phenyl) tetrahydro-2H-pyran-3-carboxylic acid benzyl ester Ib (46mg), 5-cyano-1-methyl-3- (2-nitrovinyl) -1H-indole IId (23mg), palladium catalyst Pd2(dba)3·CHCl3(5.2mg), chiral ligand IV (13.4mg), organic urea tertiary amine catalyst V (4.4mg) and
Figure BDA0003448849760000082
300mg of molecular sieve, 1mL of tetrahydrofuran is added, the flask is then brought to-10 ℃ and stirred for 12h, and the completion of IId reaction is detected by TLC. Removing the solvent from the reaction solution obtained by the reaction, and separating and purifying the obtained crude product by column chromatography (ethyl acetate: petroleum ether: 1: 20-1: 5v/v) to obtain a colorless oily substance III bd (5R,6S,7R) -6- (5-cyano-1-methyl-1H-indol-3-yl) -5- (4- (methoxycarbonyl) phenyl) -7-nitro spiro [ 2.4%]Benzyl heptane-5-carboxylate 38mg, yield 67%.
The characterization data of the product (III bd) obtained are as follows:
colorless oil, 38mg, 67% yield; dr 4:1, 86% ee;
Figure BDA0003448849760000083
(0.1,CH2Cl2);[Daicel
Figure BDA0003448849760000084
IA-U(0.46cm×25cm),n-hexane/2-propanol=80/20,v=1mL·min-1,λ=254nm,t(major)=17.1min,t(minor)=13.9min];
1H NMR(400MHz,CDCl3)δ0.78-0.83(m,1H),0.86-0.93(m,1H),1.14-1.24(m,2H),2.62(d,J=14.0Hz,1H),2.92(d,J=14.0Hz,1H),3.59(s,3H),3.93(s,3H),4.95(d,J=10.8Hz,1H),5.04(d,J=12.2Hz,1H),5.17(d,J=12.2Hz,1H),5.31(d,J=10.0Hz,1H),6.33(s,1H),7.06(dd,J=8.4,1.4Hz,2H),7.15(dd,J=6.0,3.0Hz,2H),7.21(dd,J=8.6,1.4Hz,1H),7.26-7.30(m,3H),7.34(dt,J=8.6,1.4Hz,1H),7.47(s,1H),7.78–7.89(m,2H);
13C NMR(100MHz,CDCl3)δ14.5,17.6,23.0,33.0,44.3,50.0,52.3,60.7,67.4,96.5,102.7,109.8,110.1,120.6,124.6,125.5,127.2,128.3,128.4,128.5,128.6,129.3,129.6,131.0,135.2,138.0,143.6,166.5,173.3;
HRMS(ESI)m/z calcd.for C33H30N3O6[M+H]+:564.2129,found:564.2126。
example 5
Synthesis of (5R,6S,7R) -6- (6-bromo-1-methyl-1H-indol-3-yl) -5- (4- (methoxycarbonyl) phenyl) -7-nitro-spiro [2.4] heptane-5-carboxylic acid benzyl ester III bc
The reaction route is as follows:
Figure BDA0003448849760000091
to a 5mL round bottom flask, under nitrogen, was added 5-methylene-2-oxo-3- (4- (methoxycarbonyl) phenyl) tetrahydro-2H-pyran-3-carboxylic acid benzyl ester Ib (46mg), 6-bromo-1-methyl-3- (2-nitrovinyl) -1H-indole IIc (28mg), palladium catalyst Pd2(dba)3·CHCl3(5.2mg), chiral ligand IV (13.4mg), organic urea tertiary amine catalystReagent V (4.4mg) and
Figure BDA0003448849760000092
molecular sieves 300mg, then tetrahydrofuran 1mL, then the flask was placed at-10 ℃ and stirred for 12h, and IIc reaction was complete by TLC. Removing the solvent from the reaction solution obtained in the reaction, and separating and purifying the obtained crude product by column chromatography (ethyl acetate: petroleum ether ═ 1: 20-1: 5v/v) to obtain a colorless oily substance III bc (5R,6S,7R) -6- (6-bromo-1-methyl-1H-indol-3-yl) -5- (4- (methoxycarbonyl) phenyl) -7-nitro spiro [ 2.4-]Heptane-5-carboxylic acid benzyl ester 39mg, yield 63%.
The characterization data of the product obtained (III bc) are as follows:
colorless oil, 39mg, 63% yield; dr ═ 6:1, 92% ee;
Figure BDA0003448849760000093
(0.1,CH2Cl2);[Daicel
Figure BDA0003448849760000094
IC-U(0.46cm×25cm),n-hexane/2-propanol=80/20,v=1mL·min-1,λ=254nm,t(major)=16.9min,t(minor)=15.1min];
1H NMR(400MHz,CDCl3)δ0.75-0.80(m,1H),0.85-0.93(m,1H),1.10-1.14(m,1H),1.16-1.21(m,1H),2.62(d,J=14.0Hz,1H),2.95(d,J=14.0Hz,1H),3.50(s,3H),3.91(s,3H),4.92(d,J=10.0Hz,1H),5.02(d,J=12.2Hz,1H),5.16(d,J=12.2Hz,1H),5.36(d,J=10.0Hz,1H),6.10(s,1H),7.04-7.10(m,3H),7.12–7.16(m,2H),7.21(d,J=8.6Hz,1H),7.25–7.28(m,3H),7.33(d,J=1.5Hz,1H),7.79–7.84(m,2H);
13C NMR(100MHz,CDCl3)δ14.2,17.5,23.1,32.9,44.3,49.9,52.3,61.0,67.4,97.1,109.2,112.3,115.5,121.0,122.7,126.5,128.2,128.5,128.5,128.6,129.0,129.1,129.2,135.3,137.4,143.8,166.7,173.5;
HRMS(ESI)m/z calcd.for C32H30BrN2O6[M+H]+:617.1282,found:617.1287。
example 6
Synthesis of benzyl (5R,6S,7R) -6- (6-bromo-1-methyl-1H-indol-3-yl) -5- (3- (methoxycarbonyl) phenyl) -7-nitro-spiro [2.4] heptane-5-carboxylate IIIcc
The reaction route is as follows:
Figure BDA0003448849760000101
to a 5mL round bottom flask, under nitrogen, was added 3- (3- (methoxycarbonyl) phenyl) -5-methylene-2-oxotetrahydro-2H-pyran-3-carboxylic acid benzyl ester ic (46mg), 6-bromo-1-methyl-3- (2-nitrovinyl) -1H-indolic (28mg), palladium catalyst Pd2(dba)3·CHCl3(5.2mg), chiral ligand IV (13.4mg), organic urea tertiary amine V (4.4mg) and
Figure BDA0003448849760000102
molecular sieves 300mg, then tetrahydrofuran 1mL, then the flask was placed at-10 ℃ and stirred for 12h, and IIc reaction was complete by TLC. Removing the solvent from the reaction solution obtained by the reaction, and separating and purifying the obtained crude product by column chromatography (ethyl acetate: petroleum ether: 1: 20-1: 5v/v) to obtain a colorless oily substance IIIcc (5R,6S,7R) -6- (6-bromo-1-methyl-1H-indol-3-yl) -5- (3- (methoxycarbonyl) phenyl) -7-nitro spiro [ 2.4%]Benzyl heptane-5-carboxylate 41mg, yield 67%.
The characterization data of the product obtained (IIIcc) are as follows:
41mg of a colorless oil, 67% yield; dr ═ 6:1, 85% ee;
Figure BDA0003448849760000103
(0.1,CH2Cl2);[Daicel
Figure BDA0003448849760000104
IA-U(0.46cm×25cm),n-hexane/2-propanol=90/10,v=1mL·min-1,λ=254nm,t(major)=16.1min,t(minor)=19.4min];
1H NMR(400MHz,CDCl3)δ0.76-0.82(m,1H),0.86-0.94(m,1H),1.13-1.19(m,1H),1.26-1.32(m,1H),2.63(d,J=14.0Hz,1H),2.98(d,J=14.0Hz,1H),3.51(s,3H),3.87(s,3H),4.93(d,J=10.0Hz,1H),5.04(d,J=12.2Hz,1H),5.16(d,J=12.2Hz,1H),5.36(d,J=10.0Hz,1H),6.17(s,1H),6.87–6.92(m,1H),7.00–7.07(m,2H),7.08(d,J=7.8Hz,1H),7.11–7.16(m,2H),7.24–7.29(m,3H),7.32(d,J=1.5Hz,1H),7.88(dt,J=7.8,1.3Hz,1H),7.97(d,J=2.2Hz,1H);
13C NMR(100MHz,CDCl3)δ14.0,17.9,23.3,32.8,44.2,50.3,52.2,52.3,60.9,97.1,109.2,112.2,115.4,121.0,122.6,126.4,127.7,128.2,128.4,128.5,128.7,128.9,129.4,129.9,133.7,135.4,137.4,138.9,166.8,173.6;
HRMS(ESI)m/z calcd.for C32H30BrN2O6[M+H]+:617.1282,found:617.1281;
example 7
Synthesis of methyl (5R,6S,7R) -6- (6-bromo-1-methyl-1H-indol-3-yl) -7-nitro-5- (4- (trifluoromethyl) phenyl) spiro [2.4] heptane-5-carboxylate IIIdc
The reaction route is as follows:
Figure BDA0003448849760000111
to a 5mL round bottom flask, under nitrogen, was added 5-methylene-2-oxo-3- (4- (trifluoromethyl) phenyl) tetrahydro-2H-pyran-3-carboxylic acid methyl ester Id (38mg), 6-bromo-1-methyl-3- (2-nitrovinyl) -1H-indolic (28mg), palladium catalyst Pd2(dba)3·CHCl3(5.2mg), chiral ligand IV (13.4mg), organic urea tertiary amine catalyst V (4.4mg) and
Figure BDA0003448849760000112
molecular sieves 300mg, then tetrahydrofuran 1mL, then the flask was placed at-10 ℃ and stirred for 12h, and IIc reaction was complete by TLC. Removing the solvent from the reaction solution obtained by the reaction, and separating and purifying the obtained crude product by column chromatography (ethyl acetate: petroleum ether: 1: 20-1: 5) to obtain a colorless oily substance IIIdc (5R,6S,7R) -6- (6-bromo-1-methyl-1H-indol-3-yl) -7-nitro-5- (4- (trifluoromethyl) phenyl) spiro [ 2.4%]Heptane-5-carboxylic acid methyl ester 41mg, yield 75%.
The characterization data of the product (IIIdc) obtained are as follows:
colorless oil, 41mg, 75% yield; dr ═ 5:1, 88% ee;
Figure BDA0003448849760000113
(0.1,CH2Cl2);[Daicel
Figure BDA0003448849760000114
IA-U(0.46cm×25cm),n-hexane/2-propanol=95/5,v=1mL·min-1,λ=254nm,t(major)=14.2min,t(minor)=13.5min];
1H NMR(400MHz,CDCl3)δ0.79-0.85(m,1H),0.91-0.97(m,1H),1.10-1.24(m,2H),2.61(d,J=14.0Hz,1H),3.00(d,J=14.0Hz,1H),3.54(s,3H),3.67(s,3H),4.92(d,J=10.0Hz,1H),5.36(d,J=10.0Hz,1H),6.17(s,1H),7.06-7.18(m,4H),7.35(d,J=1.8Hz,1H),7.38–7.46(m,2H);
13C NMR(100MHz,CDCl3)δ14.3,17.8,23.1,32.8,44.4,50.2,52.9,60.9,96.8,108.9,112.4,115.6,120.9,122.8,124.0(q,J=270.6Hz),124.8(q,J=3.7Hz),126.4,128.8,129.2,129.9(q,J=32.5Hz),137.4,142.8,174.2;
HRMS(ESI)m/z calcd.for C25H23BrF3N2O4[M+H]+:551.0788,found:551.0783。
example 8
Synthesis of methyl (5R,6S,7R) -6- (6-bromo-1-methyl-1H-indol-3-yl) -5- (4-bromophenyl) -7-nitrospiro [2.4] heptane-5-carboxylate III ee
The reaction route is as follows:
Figure BDA0003448849760000121
to a 5mL round bottom flask, under nitrogen, was added 3- (4-bromophenyl) -5-methylene-2-oxotetrahydro-2H-pyran-3-carboxylic acid methyl ester ie (39mg), 6-chloro-1-methyl-3- (2-nitrovinyl) -1H-indoliie (24mg), palladium catalyst Pd2(dba)3·CHCl3(5.2mg), chiral ligand IV (13.4mg), organic urea tertiary amine catalyst V (4.4mg) and
Figure BDA0003448849760000122
300mg of molecular sieve, 1mL of tetrahydrofuran is added, the flask is then brought to-10 ℃ and stirred for 12h, and the reaction of IIe is detected to be complete by TLC. Removing the solvent from the reaction solution obtained in the reaction, and separating and purifying the obtained crude product by column chromatography (ethyl acetate: petroleum ether: 1: 20-1: 5v/v) to obtain a colorless oily substance III ee (5R,6S,7R) -6- (6-bromo-1-methyl-1H-indol-3-yl) -5- (4-bromophenyl) -7-nitro spiro [2.4] spiro]29mg of methyl heptane-5-carboxylate in 56% yield.
The characterization data of the product (III ee) obtained are as follows:
colorless oil, 29mg, 52% yield; dr 4:1, 87% ee;
Figure BDA0003448849760000123
(0.1,CH2Cl2);[Daicel
Figure BDA0003448849760000124
IC-U(0.46cm×25cm),n-hexane/2-propanol=90/10,v=1mL·min-1,λ=254nm,t(major)=9.6min,t(minor)=11.2min];
1H NMR(400MHz,CDCl3)δ0.70-0.76(m,1H),0.83-0.88(m,1H),1.02-1.08(m,1H),1.10-1.15(m,1H),2.49(d,J=13.8Hz,1H),2.90(d,J=13.8Hz,1H),3.51(s,3H),3.59(s,3H),4.85(d,J=10.0Hz,1H),5.26(d,J=10.0Hz,1H),6.12(s,1H),6.81(d,J=8.6Hz,2H),7.08(dd,J=8.6,1.7Hz,1H),7.18(d,J=8.6Hz,1H),7.20–7.26(m,2H)7.30(d,J=1.7Hz,1H);
13C NMR(100MHz,CDCl3)δ14.3,17.6,23.0,32.9,44.5,50.0,52.8,60.5,97.0,109.2,112.4,115.6,121.0,121.8,122.8,126.6,129.2,130.2,131.0,137.4,137.8,174.4;
HRMS(ESI)m/z calcd.for C24H23BrClN2O4[M+H]+:517.0530,found:517.0535。
example 9
Synthesis of methyl (5R,6S,7R) -6- (1-methyl-1H-indol-3-yl) -7-nitro-5-phenylspiro [2.4] heptane-5-carboxylate IIIfa
The reaction route is as follows:
Figure BDA0003448849760000131
to a 5mL round bottom flask, under nitrogen, was added 5-methylene-2-oxo-3-phenyltetrahydro-2H-pyran-3-carboxylic acid methyl ester if (30mg), 1-methyl-3- (2-nitrovinyl) -1H-indole IIa (20mg), palladium catalyst Pd2(dba)3·CHCl3(5.2mg), chiral ligand IV (13.4mg), organic urea tertiary amine catalyst V (4.4mg) and
Figure BDA0003448849760000134
300mg of molecular sieve, 1mL of tetrahydrofuran is added, the flask is then brought to-10 ℃ and stirred for 12h, and the completion of IIa reaction is detected by TLC. Removing the solvent from the reaction solution obtained by the reaction, and separating and purifying the obtained crude product by column chromatography (ethyl acetate: petroleum ether ═ 1: 20-1: 5v/v) to obtain a colorless oily substance IIIfa (5R,6S,7R) -6- (1-methyl-1H-indol-3-yl) -7-nitro-5-phenyl spiro [ 2.4-]Heptane-5-carboxylic acid methyl ester 23mg, yield 57%.
The characterization data of the product (IIIfa) obtained are as follows:
colorless oil, 23mg, 57% yield; dr ═ 12:1, 87% ee;
Figure BDA0003448849760000132
(0.1,CH2Cl2);[Daicel
Figure BDA0003448849760000133
IB-U(0.46cm×25cm),n-hexane/2-propanol=95/5,v=1mL·min-1,λ=254nm,t(major)=8.5min,t(minor)=8.2min];
1H NMR(400MHz,CDCl3)δ0.77-0.82(m,1H),0.89-0.95(m,1H),1.09-1.16(m,1H),1.18-1.23(m,1H),2.63(d,J=13.8Hz,1H),2.98(d,J=13.8Hz,1H),3.56(s,3H),3.66(s,3H),5.01(d,J=10.0Hz,1H),5.39(d,J=10.0Hz,1H),6.10(s,1H),6.98-7.07(m,3H),7.11-7.24(m,5H),7.37(d,J=8.0Hz,1H)
13C NMR(100MHz,CDCl3)δ14.3,17.6,23.0,32.9,44.5,50.0,52.8,60.4,96.9,109.2,112.3,115.5,121.0,122.7,126.6,128.0,129.2,129.8,133.6,137.2,137.4,174.4
HRMS(ESI)m/z calcd.for C24H25N2O4[M+H]+:405.1809,found:405.1811。
comparative example 1
Synthesis of benzyl (5R,6S,7R) -6- (1-methyl-1H-indol-3-yl) -7-nitro-5-phenylspiro [2.4] heptane-5-carboxylate IIIaa as in example 1 except that: the chiral ligand IV and the organic urea tertiary amine catalyst V are not added, the yield of the obtained target product is 58 percent, the dr value is 1:1, and the ee value is 0.
In the comparative example, chiral ligand IV and organic urea tertiary amine catalyst V are not added, the yield of the obtained target product is low, stereoselectivity is avoided, and a racemic product is obtained.
Comparative example 2
Synthesis of benzyl (5R,6S,7R) -6- (1-methyl-1H-indol-3-yl) -7-nitro-5-phenylspiro [2.4] heptane-5-carboxylate IIIaa as in example 1 except that: no tertiary amine catalyst V was added, and the yield of the obtained target product was 67%, dr value was 1:1, and ee value was 85%.
In the comparative example, a mobile phone tertiary amine catalyst V is not added, so that the enantioselectivity of the obtained target product is reduced, and the diastereoselectivity is poor.
Comparative example 3
Synthesis of benzyl (5R,6S,7R) -6- (1-methyl-1H-indol-3-yl) -7-nitro-5-phenylspiro [2.4] heptane-5-carboxylate IIIaa as in example 1 except that: toluene was used as a solvent, and the yield of the objective product was 60%, dr value was 2:1, and ee value was 55%.
In the comparative example, the solvent is toluene, the yield of the obtained target product is low, the enantioselectivity is reduced, and the diastereoselectivity is poor.
Comparative example 4
Synthesis of benzyl (5R,6S,7R) -6- (1-methyl-1H-indol-3-yl) -7-nitro-5-phenylspiro [2.4] heptane-5-carboxylate IIIaa as in example 1 except that: the chiral ligand VI-1 is used to replace the chiral ligand IV, the yield of the target product is 40 percent, the dr value is 1:1, and the ee value is 39 percent.
Figure BDA0003448849760000141
In the comparative example, the chiral ligand VI-1 is used as the solvent, so that the yield of the obtained target product is obviously reduced, the enantioselectivity is reduced, and the diastereoselectivity is poor.
The above embodiments are only some examples of the present invention, and the present invention is not limited thereto in any way, and any simple modification, equivalent change and modification to the above embodiments according to the technical spirit of the present invention are within the technical scope of the present invention.

Claims (10)

1. A process for the preparation of chiral spiro [2.4] heptanes by palladium catalysed asymmetric cycloaddition comprising the steps of:
in a solvent, under the concerted catalysis of a palladium catalysis system and an organic urea tertiary amine catalyst, performing cycloaddition reaction on a gamma-methylene-delta-valerolactone compound I and an indole nitroolefin compound II to obtain a chiral spiro [2.4] heptane compound III; the palladium catalytic system consists of a palladium catalyst and a chiral ligand, and the chiral ligand has a structure shown in a formula IV; the organic urea tertiary amine catalyst has a structure shown in a formula V;
Figure FDA0003448849750000011
wherein in the structural formula of the compound of the formula I, R1Selected from C1-C3 alkyl or benzyl; ar is phenyl or substituted phenyl, and the substituent of the substituted phenyl is trifluoromethyl, halogen or methyl formate;
in the structural formula of the compound of formula II, R2Is hydrogen, cyano, halogen or C1-C3 alkyl;
in the formula of the compound of formula III, the substituent R1Ar is the same as the structural formula of the compound shown in the formula I; substituent R2And the substitution position is the same as that in the structural formula of the compound shown in the formula II.
2. Preparation of chiral spiro [2.4] according to claim 1]The method for preparing the heptane compounds is characterized in that in the structural formula of the compound shown in the formula I, R is1Is methyl, ethyl or benzyl; ar is phenyl, 4-trifluoromethylphenyl, 4-chlorphenyl, 4-bromophenyl, 4-carbomethoxyphenyl or 3-carbomethoxyphenyl.
3. The process for preparing chiral spiro [2.4] heptanes according to claim 1, wherein the solvent is tetrahydrofuran, anisole or N, N-dimethylformamide; the ratio of the volume of the solvent to the mole number of the indole nitroolefin compound II is 1mL: 0.05-0.5 mmol; the solvent is an anhydrous and oxygen-free solvent.
4. Preparation of chiral spiro [2.4] according to claim 1]The method for preparing heptane compounds is characterized in that the palladium catalyst is Pd2(dba)3·CHCl3Or Pd (PPh)3)4(ii) a The molar ratio of palladium in the palladium catalyst to the indole nitroolefin compound II is 0.1-0.11: 1; the molar ratio of palladium to the chiral ligand in the palladium catalyst is 1: 2-2.2.
5. The process for preparing chiral spiro [2.4] heptanes according to claim 1, wherein the molar ratio of the organic urea tertiary amine catalyst to palladium in the palladium catalyst is 1: 1.
6. The method for preparing chiral spiro [2.4] heptane compounds according to claim 1, wherein the molar ratio of the gamma-methylene-delta-valerolactone compound I and the indole nitroolefin compound II is 1-1.2: 1.
7.Preparation of chiral spiro [2.4] according to claim 1]The method for producing heptane compounds is characterized in that the reaction system is added with
Figure FDA0003448849750000021
A molecular sieve; the above-mentioned
Figure FDA0003448849750000022
The ratio of the mass of the molecular sieve to the number of moles of the indole nitroolefin compound II is 2-5 g:1 mmol.
8. The method of claim 1, wherein the cycloaddition reaction is performed under a protective gas atmosphere, wherein the protective gas is nitrogen or argon.
9. The process for the preparation of chiral spiro [2.4] heptanes according to claim 1, characterized in that the temperature of the cycloaddition reaction is-30 ℃ to 0 ℃, preferably-10 ℃ to 0 ℃; the time of the cycloaddition reaction is 1-14 h.
10. The method for preparing chiral spiro [2.4] heptanes according to claim 1, wherein the post-treatment step of the reaction solution obtained after cycloaddition reaction of γ -methylene- δ -valerolactone i and indole nitroolefin compound is as follows: removing the solvent from the reaction liquid, and performing silica gel column chromatography separation on the obtained crude product to obtain a chiral spiro [2.4] heptane compound III, wherein the eluent is a mixed solvent of ethyl acetate and petroleum ether, and the volume ratio of the ethyl acetate to the petroleum ether in the mixed solvent is 0.01-0.5: 1.
CN202111668135.1A 2021-12-30 2021-12-30 Method for preparing chiral spiro [2.4] heptane compounds through palladium-catalyzed asymmetric cycloaddition reaction Pending CN114426511A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111668135.1A CN114426511A (en) 2021-12-30 2021-12-30 Method for preparing chiral spiro [2.4] heptane compounds through palladium-catalyzed asymmetric cycloaddition reaction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111668135.1A CN114426511A (en) 2021-12-30 2021-12-30 Method for preparing chiral spiro [2.4] heptane compounds through palladium-catalyzed asymmetric cycloaddition reaction

Publications (1)

Publication Number Publication Date
CN114426511A true CN114426511A (en) 2022-05-03

Family

ID=81312188

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111668135.1A Pending CN114426511A (en) 2021-12-30 2021-12-30 Method for preparing chiral spiro [2.4] heptane compounds through palladium-catalyzed asymmetric cycloaddition reaction

Country Status (1)

Country Link
CN (1) CN114426511A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105732550A (en) * 2014-12-09 2016-07-06 中国科学院大连化学物理研究所 Preparing method of chiral 3-methylene-2,3-dihydro-furan compound
CN112430236A (en) * 2020-11-27 2021-03-02 暨南大学 Synthesis method of chiral spiro [ pyrrolidone-3, 3 '-oxindole ] ring system and application of chiral spiro [ pyrrolidone-3, 3' -oxindole ] ring system in synthesis of natural product
CN113200905A (en) * 2021-03-31 2021-08-03 中山大学 Chiral indolone derivative and synthesis method thereof
CN113620918A (en) * 2021-08-18 2021-11-09 山东大学 Method for synthesizing spiro compound through Lewis acid catalyzed [3+2] cycloaddition reaction
CN113666862A (en) * 2021-08-18 2021-11-19 山东大学 Method for preparing chiral 3-nitroindole compound by nickel-catalyzed asymmetric nitration reaction

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105732550A (en) * 2014-12-09 2016-07-06 中国科学院大连化学物理研究所 Preparing method of chiral 3-methylene-2,3-dihydro-furan compound
CN112430236A (en) * 2020-11-27 2021-03-02 暨南大学 Synthesis method of chiral spiro [ pyrrolidone-3, 3 '-oxindole ] ring system and application of chiral spiro [ pyrrolidone-3, 3' -oxindole ] ring system in synthesis of natural product
CN113200905A (en) * 2021-03-31 2021-08-03 中山大学 Chiral indolone derivative and synthesis method thereof
CN113620918A (en) * 2021-08-18 2021-11-09 山东大学 Method for synthesizing spiro compound through Lewis acid catalyzed [3+2] cycloaddition reaction
CN113666862A (en) * 2021-08-18 2021-11-19 山东大学 Method for preparing chiral 3-nitroindole compound by nickel-catalyzed asymmetric nitration reaction

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
B. M. TROST等: "Palladium-Catalyzed Enantioselective Cycloadditions of Aliphatic 1, 4-Dipoles: Access to Chiral Cyclohexanes and Spiro [2.4] heptanes", 《J. AM. CHEM. SOC.》, vol. 142, no. 43, pages 18628 *

Similar Documents

Publication Publication Date Title
Fan et al. Rhodium‐Catalyzed Asymmetric Pauson–Khand Reaction Using Monophosphoramidite Ligand SIPHOS
CN113583015A (en) Method for synthesizing chiral oxygen-containing eight-membered ring compound through palladium-catalyzed asymmetric allylic cycloaddition reaction
CN114437103B (en) Method for synthesizing chiral tetrahydrobenzoxepin compound through gold-catalyzed asymmetric cycloaddition reaction
CN113549062B (en) Chiral quaternary ammonium salt phase transfer catalyst with high steric hindrance derived from cinchona alkaloid and synthesis method thereof
CN114805068A (en) Preparation method of chiral alpha-hydroxy-beta-keto ester compound
JP2010512379A (en) process
CN112940002B (en) Method for synthesizing octatomic bridged ring compound through palladium-catalyzed asymmetric ring addition reaction
CN111925356B (en) Synthesis method and application of chiral quinoline-imidazoline ligand
CN111848322B (en) Axial chiral oxindole-substituted styrene compound and resolution method and application thereof
CN114426511A (en) Method for preparing chiral spiro [2.4] heptane compounds through palladium-catalyzed asymmetric cycloaddition reaction
CN111718372A (en) Axial chiral phosphine-alkene ligand and preparation method and application thereof
CN107522645B (en) Method for preparing polysubstituted pyrrole compound
CN116199713A (en) Chiral alpha-aminophosphonic acid derivative and preparation method thereof
CN113754605B (en) Nitrogen-containing ligand, and preparation method and application thereof
CN113754604B (en) Nitrogen-containing chiral ligand and application thereof in asymmetric oxidation reaction of thioether
US20040019204A1 (en) Intramolecular amidation of sulfamate esters catalyzed by metalloporphyrins
CN109503387B (en) Method for catalyzing asymmetric synthesis of binaphthyl diamine
JP3843470B2 (en) Ferrocenyl diphenylphosphine derivative, hydrosilylation with the ligand metal complex
JP2010030992A (en) Method for producing optically active amine compound
CN111170918A (en) Method for synthesizing gamma-lactam and delta-lactam through C-H amine
JPH1072430A (en) Production of optically active sulfoxide compound
JP2015172024A (en) Chiral bicyclic diene ligand having hydrogen bond formation amide group
CN115448867B (en) Chiral pyrrolidine and tetrahydrofuran ring compound and preparation method thereof
JP4279872B2 (en) Method for producing optically active nitro compound
CN114426564B (en) Chiral ferrocene phosphine-1, 2-diphenyl ethylenediamine ligand and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination